Advances and failures in preventing perinatal human immunodeficiency virus infection

Clinical Microbiology Reviews

Volumn 22, Issue 3, 2009, Pages 493-507

  Buchanan, Ann M ^a   Cunningham, Coleen K ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE PLUS ZIDOVUDINE; NEVIRAPINE; PLACEBO; ZIDOVUDINE;

ABNORMAL LABORATORY RESULT; ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; BREAST FEEDING; CLINICAL TRIAL; COGNITIVE DEFECT; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG WITHDRAWAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HYPERLACTATEMIA; INFECTION PREVENTION; INFECTION RISK; LACTATE BLOOD LEVEL; METABOLIC ACIDOSIS; NEUROLOGIC DISEASE; PATIENT COUNSELING; PERINATAL INFECTION; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS; REVIEW; SEIZURE; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; SINGLE DRUG DOSE; UNITED STATES; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BREAST FEEDING; CHEMOPREVENTION; CHILD; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 67651005174     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00054-08     Document Type: Review

References (98)

1. Alimenti, A., D. R. Burdge, G. S. Ogilvie, D. M. Money, and J. C. Forbes. 2003. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy. Pediatr. Infect. Dis. J. 22:782-789.
2. Ammann, A. J. 1983. Is there an acquired immune deficiency syndrome in infants and children? Pediatrics 72:430-432.
3. Arrive, E., M. L. Newell, D. K. Ekouevi, M. L. Chaix, R. Thiebaut, B. Masquelier, V. Leroy, P. V. Perre, C. Rouzioux, and F. Dabis. 2007. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int. J. Epidemiol. 36:1009-1021.
4. Barret, B., M. Tardieu, P. Rustin, C. Lacroix, B. Chabrol, I. Desguerre, C. Dollfus, M. J. Mayaux, and S. Blanche. 2003. Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort. AIDS 17:1769-1785.
5. Bedri, A., B. Gudetta, A. Isehak, S. Kumbi, S. Lulseged, Y. Mengistu, A. V. Bhore, R. Bhosale, V. Varadhrajan, N. Gupte, J. Sastry, N. Suryavanshi, S. Tripathy, F. Mmiro, M. Mubiru, C. Onyango, A. Taylor, P. Musoke, C. Nakabiito, A. Abashawl, R. Adamu, G. Antelman, R. C. Bollinger, P. Bright, M. A. Chaudhary, J. Coberly, L. Guay, M. G. Fowler, A. Gupta, E. Hassen, J. B. Jackson, L. H. Moulton, U. Nayak, S. B. Omer, L. Propper, M. Ram, V. Rexroad, A. J. Ruff, A. Shankar, and S. Zwerski. 2008. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 372:300-313.
6. Blanche, S., M. Tardieu, P. Rustin, A. Slama, B. Barret, G. Firtion, N. Ciraru-Vigneron, C. Lacroix, C. Rouzioux, L. Mandelbrot, I. Desguerre, A. Rotig, M. J. Mayaux, and J. F. Delfraissy. 1999. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 354:1084-1089.
7. Branson, B. M., H. H. Handsfield, M. A. Lampe, R. S. Janssen, A. W. Taylor, S. B. Lyss, and J. E. Clark. 2006. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recommend. Rep. 55:1-17; quiz CE1-4.
8. Bwirire, L. D., M. Fitzgerald, R. Zachariah, V. Chikafa, M. Massaquoi, M. Moens, K. Kamoto, and E. J. Schouten. 2008. Reasons for loss to follow-up among mothers registered in a prevention-of-mother-to-child transmission program in rural Malawi. Trans. R. Soc. Trop. Med. Hyg. 102:1195-1200.
9. Centers for Disease Control and Prevention. 1985. Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome. MMWR Morb. Mortal. Wkly. Rep. 34:721-726, 731-732.
10. Centers for Disease Control and Prevention. 2001. Revised recommendations for HIV screening of pregnant women. MMWR Recommend. Rep. 50:63-85; quiz CE1-19a2-CE6-19a2.
11. Centers for Disease Control and Prevention. 2006. Twenty-five years of HIV/AIDS-United States, 1981-2006. MMWR Morb. Mortal. Wkly. Rep. 55:585-589.
12. Centers for Disease Control and Prevention. 1995. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Recommend. Rep. 44:1-15.
13. Centers for Disease Control and Prevention. 1982. Unexplained immunodeficiency and opportunistic infections in infants-New York, New Jersey, California. MMWR Morb. Mortal. Wkly. Rep. 31:665-667.
14. Centers for Disease Control and Prevention. 2007. HIV/AIDS surveillance in women. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/hiv/topics/surveillance/resources/slides/women/index.htm.
15. Centers for Disease Control and Prevention. 5 May 2008, posting date. New estimates of U.S. HIV prevalence, 2006. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/hiv/topics/surveillance/ resources/slides/women/index.htm.
16. Centers for Disease Control and Prevention. 11 September 2008, posting date. New HIV incidence estimates: CDC responds. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/hiv/topics/surveillance/ resources/factsheets/response.htm.
17. Centers for Disease Control and Prevention. November 2007, posting date. Reducing HIV transmission from mother-to-child: an opt-out approach to HIV screening. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/hiv/topics/perinatal/resources/factsheets/opt-out.htm.
18. Central Intelligence Agency. 12 May 2009, posting date. The 2008 World Factbook. Central Intelligence Agency, McLean, VA. http://www.cia.gov/ library/publications/the-world-factbook/.
19. Chersich, M. F., M. F. Urban, F. W. Venter, T. Wessels, A. Krause, G. E. Gray, S. Luchters, and D. L. Viljoen. 2006. Efavirenz use during pregnancy and for women of child-bearing potential. AIDS Res. Ther. 3:11.
20. Chi, B. H., N. Chintu, R. A. Cantrell, C. Kankasa, G. Kruse, F. Mbewe, M. Sinkala, P. J. Smith, E. M. Stringer, and J. S. Stringer. 2008. Addition of single-dose tenofovir and emtricitabine to intrapartum nevirapine to reduce perinatal HIV transmission. J. Acquir. Immune Defic. Syndr. 48:220-223.
21. Chi, B. H., M. Sinkala, F. Mbewe, R. A. Cantrell, G. Kruse, N. Chintu, G. M. Aldrovandi, E. M. Stringer, C. Kankasa, J. T. Safrit, and J. S. Stringer. 2007. Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial. Lancet 370:1698-1705.
22. Cleland, J., S. Bernstein, A. Ezeh, A. Faundes, A. Glasier, and J. Innis. 2006. Family planning: the unfinished agenda. Lancet 368:1810-1827.
23. Connor, E. M., R. S. Sperling, R. Gelber, P. Kiselev, G. Scott, M. J. O'Sullivan, R. VanDyke, M. Bey, W. Shearer, R. L. Jacobson, et al. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N. Engl. J. Med. 331:1173-1180.
24. Cooper, E. R., M. Charurat, L. Mofenson, I. C. Hanson, J. Pitt, C. Diaz, K. Hayani, E. Handelsman, V. Smeriglio, R. Hoff, and W. Blattner. 2002. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J. Acquir. Immune Defic. Syndr. 29:484-494.
25. Coovadia, H. M., N. C. Rollins, R. M. Bland, K. Little, A. Coutsoudis, M. L. Bennish, and M. L. Newell. 2007. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 369:1107-1116.
26. Coutsoudis, A., F. Dabis, W. Fawzi, P. Gaillard, G. Haverkamp, D. R. Harris, J. B. Jackson, V. Leroy, N. Meda, P. Msellati, M. L. Newell, R. Nsuati, J. S. Read, and S. Wiktor. 2004. Late postnatal transmission of HIV-1 in breastfed children: an individual patient data meta-analysis. J. Infect. Dis. 189:2154-2166.
27. Cowan, M. J., D. Hellmann, D. Chudwin, D. W. Wara, R. S. Chang, and A. J. Ammann. 1984. Maternal transmission of acquired immune deficiency syndrome. Pediatrics 73:382-386.
28. Dao, H., L. M. Mofenson, R. Ekpini, C. F. Gilks, M. Barnhart, O. Bolu, and N. Shaffer. 2007. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update. Am. J. Obstet Gynecol. 197:S42-S55.
29. Doherty, T., M. Chopra, L. Nkonki, D. Jackson, and T. Greiner. 2006. Effect of the HIV epidemic on infant feeding in South Africa: "When they see me coming with the tins they laugh at me". Bull. W. H. O. 84:90-96.
30. Ekouevi, D. K., R. Toure, R. Becquet, I. Viho, C. Sakarovitch, F. Rouet, B. Towne-Gold, P. Fassinou, V. Leroy, S. Blanche, F. Dabis, et al. 2006. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV. Pediatrics 118:e1071-e1077.
31. Eshleman, S. H., D. R. Hoover, S. E. Hudelson, S. Chen, S. A. Fiscus, E. Piwowar-Manning, J. B. Jackson, N. I. Kumwenda, and T. E. Taha. 2006. Development of nevirapine resistance in infants is reduced by use of infantonly single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1. J. Infect. Dis. 193:479-481.
32. European Collaborative Study. 2004. Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers. AIDS 18:2009-2017.
33. European Mode of Delivery Collaboration. 1999. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 353:1035-1039.
34. Eyakuze, C., D. A. Jones, A. M. Starrs, and N. Sorkin. 2008. From PMTCT to a more comprehensive AIDS response for women: a much-needed shift. Dev. World Bioeth. 8:33-42.
35. Garcia, P. M., L. A. Kalish, J. Pitt, H. Minkoff, T. C. Quinn, S. K. Burchett, J. Kornegay, B. Jackson, J. Moye, C. Hanson, C. Zorrilla, J. F. Lew, et al. 1999. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N. Engl. J. Med. 341:394-402.
36. Guay, L. A., P. Musoke, T. Fleming, D. Bagenda, M. Allen, C. Nakabiito, J. Sherman, P. Bakaki, C. Ducar, M. Deseyve, L. Emel, M. Mirochnick, M. G. Fowler, L. Mofenson, P. Miotti, K. Dransfield, D. Bray, F. Mmiro, and J. B. Jackson. 1999. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 354:795-802.
37. HIV Prevention Trials Network 027. 2008, posting date. A phase I study to evaluate the safety and immunogenicity of ALVAC-HIV vCP1521 in infants born to HIV-1-infected women in Uganda. http://www.hptn.org/research-studies/ HPTN027.asp.
38. Iliff, P. J., E. G. Piwoz, N. V. Tavengwa, C. D. Zunguza, E. T. Marinda, K. J. Nathoo, L. H. Moulton, B. J. Ward, and J. H. Humphrey. 2005. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 19:699-708.
39. Jackson, J. B., P. Musoke, T. Fleming, L. A. Guay, D. Bagenda, M. Allen, C. Nakabiito, J. Sherman, P. Bakaki, M. Owor, C. Ducar, M. Deseyve, A. Mwatha, L. Emel, C. Duefield, M. Mirochnick, M. G. Fowler, L. Mofenson, P. Miotti, M. Gigliotti, D. Bray, and F. Mmiro. 2003. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet 362:859-868.
40. Jamieson, D. J., J. Clark, A. P. Kourtis, A. W. Taylor, M. A. Lampe, M. G. Fowler, and L. M. Mofenson. 2007. Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States. Am. J. Obstet Gynecol. 197:S26-32.
41. Jaspan, H. B., and R. F. Garry. 2003. Preventing neonatal HIV: a review. Curr. HIV Res. 1:321-327.
42. John, G. C., R. W. Nduati, D. A. Mbori-Ngacha, B. A. Richardson, D. Panteleeff, A. Mwatha, J. Overbaugh, J. Bwayo, J. O. Ndinya-Achola, and J. K. Kreiss. 2001. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J. Infect. Dis. 183:206-212.
43. John-Stewart, G., D. Mbori-Ngacha, R. Ekpini, E. N. Janoff, J. Nkengasong, J. S. Read, P. Van de Perre, and M. L. Newell. 2004. Breast-feeding and transmission of HIV-1. J. Acquir. Immune Defic. Syndr. 35:196-202.
44. Joint United Nations Programme on HIV/AIDS. August 2008, posting date. 2008 report on the global AIDS epidemic. UNAIDS, Geneva, Switzerland. http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/ 2008-Global-report.
45. Joint United Nations Programme on HIV/AIDS. December 2005, posting date. AIDS Epidemic Update. UNAIDS/WHO, Geneva, Switzerland. http://data.unaids.org/Publications/IRC-pub06/epi-update2005-en.pdf.
46. Joint United Nations Programme on HIV/AIDS, United Nations Children's Fund, World Health Organization. April 2008, posting date. Children and AIDS: second stocktaking report. UNICEF, New York, NY. http://www.unicef.org/ publications/index-43451.html.
47. Joint United Nations Programme on HIV/AIDS/World Health Organization. 19 November 2007, posting date. AIDS epidemic update. UNAIDS/WHO. http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/ EpiUpdArchive/2007/.
48. Joint United Nations Programme on HIV/AIDS/World Health Organization. 16 April 2008, posting date. Sub-Saharan Africa AIDS epidemic update regional summary. UNAIDS/WHO, Geneva, Switzerland. http://www.unaids.org/ en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2007/.
49. Joint United Nations Programme on HIV/AIDS. 2009, posting date. About UNAIDS. UNAIDS, Geneva, Switzerland. http://www.unaids.org/en/AboutUNAIDS/ default.asp.
50. Jourdain, G., N. Ngo-Giang-Huong, S. Le Coeur, C. Bowonwatanuwong, P. Kantipong, P. Leechanachai, S. Ariyadej, P. Leenasirimakul, S. Hammer, and M. Lallemant. 2004. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N. Engl. J. Med. 351:229-240.
51. Kaneda, T., K. Shiraki, K. Hirano, and I. Nagata. 1997. Detection of maternofetal transfusion by placental alkaline phosphatase levels. J. Pediatr. 130:730-735.
52. Kasenga, F., A. K. Hurtig, and M. Emmelin. 2008. HIV-positive women's experiences of a PMTCT programme in rural Malawi. Midwifery [Epub ahead of print.] doi:10.1016/j.midw.2008.04.007.
53. Kumwenda, N. I., D. R. Hoover, L. M. Mofenson, M. C. Thigpen, G. Kafulafula, Q. Li, L. Mipando, K. Nkanaunena, T. Mebrahtu, M. Bulterys, M. G. Fowler, and T. E. Taha. 2008. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N. Engl. J. Med. 359:119-129.
54. Lallemant, M., G. Jourdain, S. Le Coeur, J. Y. Mary, N. Ngo-Giang-Huong, S. Koetsawang, S. Kanshana, K. McIntosh, and V. Thaineua. 2004. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-tochild transmission of HIV-1 in Thailand. N. Engl. J. Med. 351:217-228.
55. Lockman, S., R. L. Shapiro, L. M. Smeaton, C. Wester, I. Thior, L. Stevens, F. Chand, J. Makhema, C. Moffat, A. Asmelash, P. Ndase, P. Arimi, E. van Widenfelt, L. Mazhani, V. Novitsky, S. Lagakos, and M. Essex. 2007. Response to antiretroviral therapy after a single, peripartum dose of nevirapine. N. Engl. J. Med. 356:135-147.
56. Lyons, F., S. Hopkins, B. Kelleher, A. McGeary, G. Sheehan, J. Geoghegan, C. Bergin, F. M. Mulcahy, and P. A. McCormick. 2006. Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy. HIV Med. 7:255-260.
57. Mandelbrot, L., M. J. Mayaux, A. Bongain, A. Berrebi, Y. Moudoub-Jeanpetit, J. L. Benifla, N. Ciraru-Vigneron, J. Le Chenadec, S. Blanche, and J. F. Delfraissy. 1996. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. Am. J. Obstet Gynecol. 175:661-667.
58. Martinson, N. A., D. K. Ekouevi, F. Dabis, L. Morris, P. Lupodwana, B. Tonwe-Gold, P. Dhlamini, R. Becquet, J. G. Steyn, V. Leroy, I. Viho, G. E. Gray, and J. A. McIntyre. 2007. Transmission rates in consecutive pregnancies exposed to single-dose nevirapine in Soweto, South Africa and Abidjan, Cote d'Ivoire. J. Acquir. Immune Defic. Syndr. 45:206-209.
59. Marum, E., M. Taegtmeyer, and K. Chebet. 2006. Scale-up of voluntary HIV counseling and testing in Kenya. JAMA 296:859-862.
60. Mayaux, M. J., S. Blanche, C. Rouzioux, J. Le Chenadec, V. Chambrin, G. Firtion, M. C. Allemon, E. Vilmer, N. C. Vigneron, J. Tricoire, et al. 1995. Maternal factors associated with perinatal HIV-1 transmission: the French Cohort Study: 7 years of follow-up observation. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 8:188-194.
61. McIntyre, J. A., N. Martinson, G. E. Gray. 2005. Single dose nevirapine combined with a short course of combivir for prevention of mother to child transmission of HIV-1 can significantly decrease the subsequent development of maternal and infant resistant virus. Antivir. Ther. 10:S4.
62. Minkoff, H., D. N. Burns, S. Landesman, J. Youchah, J. J. Goedert, R. P. Nugent, L. R. Muenz, and A. D. Willoughby. 1995. The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am. J. Obstet. Gynecol. 173:585-589.
63. Mirochnick, M., A. Dorenbaum, S. Blanchard, C. K. Cunningham, R. D. Gelber, L. Mofenson, M. Culnane, and J. L. Sullivan. 2003. Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine dose. J. Acquir. Immune Defic. Syndr. 33:153-156.
64. Mirochnick, M., K. Nielsen-Saines, J. H. Pilotto, J. Pinto, E. Jimenez, V. G. Veloso, T. Parsons, D. H. Watts, J. Moye, L. M. Mofenson, M. Camarca, and Y. Bryson. 2008. Nevirapine concentrations in newborns receiving an extended prophylactic regimen. J. Acquir. Immune Defic. Syndr. 47:334-337.
65. Mofenson, L. M., J. S. Lambert, E. R. Stiehm, J. Bethel, W. A. Meyer III, J. Whitehouse, J. Moye, Jr., P. Reichelderfer, D. R. Harris, M. G. Fowler, B. J. Mathieson, G. J. Nemo, et al. 1999. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N. Engl. J. Med. 341:385-393.
66. Moses, A., C. Zimba, E. Kamanga, J. Nkhoma, A. Maida, F. Martinson, I. Mofolo, G. Joaki, J. Muita, A. Spensley, I. Hoffman, and C. M. van der Horst. 2008. Prevention of mother-to-child transmission: program changes and the effect on uptake of the HIVNET 012 regimen in Malawi. AIDS 22:83-87.
67. National HIV/AIDS Clinicians' Consultation Center. 17 March 2009, posting date. Compendium of State HIV Testing Laws-2009. University of California, San Francisco. http://www.nccc.ucsf.edu/StateLaws/Index.html.
68. Newell, M. L. 2006. Current issues in the prevention of mother-to-child transmission of HIV-1 infection. Trans. R. Soc. Trop. Med. Hyg. 100:1-5.
69. Newell, M. L., D. T. Dunn, C. S. Peckham, A. E. Semprini, G. Pardi, et al. 1996. Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS 10:1675-1681.
70. Noguera, A., C. Fortuny, E. Sanchez, R. Artuch, M. A. Vilaseca, C. Munoz-Almagro, J. Pou, and R. Jimenez. 2003. Hyperlactatemia in human immunodeficiency virus-infected children receiving antiretroviral treatment. Pediatr. Infect. Dis. J. 22:778-782.
71. Oleske, J., A. Minnefor, R. Cooper, Jr., K. Thomas, A. dela Cruz, H. Ahdieh, I. Guerrero, V. V. Joshi, and F. Desposito. 1983. Immune deficiency syndrome in children. JAMA 249:2345-2349.
72. Pitt, J., D. Brambilla, P. Reichelderfer, A. Landay, K. McIntosh, D. Burns, G. V. Hillyer, H. Mendez, and M. G. Fowler. 1997. Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: findings from the Women and Infants Transmission Study. J. Infect. Dis. 175:567-575.
73. President's Emergency Plan for AIDS Relief. 2007. The power of partnerships: third annual report to Congress on PEPFAR. PEPFAR, Washington, DC.
74. Public Health Service Task Force. 8 July 2008, posting date. Recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. Public Health Service, Washington, DC. http://aidsinfo.nih.gov/contentfiles/PerinatalGL001020.pdf.
75. Read, J. S. 2006. Prevention of mother-to-child transmission of HIV, p. 107-133. In S. L. Zeichner and J. S. Read (ed.), Handbook of pediatric HIV care. Cambridge University Press, Cambridge, United Kingdom.
76. Reynolds, H. W., B. Janowitz, R. Wilcher, and W. Cates. 2008. Contraception to prevent HIV-positive births: current contribution and potential cost savings in PEPFAR countries. Sex. Transm. Infect. 84(Suppl. 2):49-53.
77. Reynolds, H. W., M. J. Steiner, and W. Cates, Jr. 2005. Contraception's proved potential to fight HIV. Sex. Transm. Infect. 81:184-185.
78. Rubinstein, A., M. Sicklick, A. Gupta, L. Bernstein, N. Klein, E. Rubinstein, I. Spigland, L. Fruchter, N. Litman, H. Lee, and M. Hollander. 1983. Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA 249:2350-2356.
79. Sansom, S. L., D. J. Jamieson, P. G. Farnham, M. Bulterys, and M. G. Fowler. 2003. Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission. Obstet. Gynecol. 102:782-790.
80. Scalfaro, P., J. J. Chesaux, P. A. Buchwalder, J. Biollaz, and J. L. Micheli. 1998. Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment. Intensive Care Med. 24:247-250.
81. Scott, G. B., B. E. Buck, J. G. Leterman, F. L. Bloom, and W. P. Parks. 1984. Acquired immunodeficiency syndrome in infants. N. Engl. J. Med. 310:76-81.
82. Shaffer, N., R. Chuachoowong, P. A. Mock, C. Bhadrakom, W. Siriwasin, N. L. Young, T. Chotpitayasunondh, S. Chearskul, A. Roongpisuthipong, P. Chinayon, J. Karon, T. D. Mastro, R. J. Simonds, et al. 1999. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet. 353:773-780.
83. Spensley, A., T. Sripipatana, A. N. Turner, C. Hoblitzelle, J. Robinson, and C. Wilfert. 2009. Preventing mother-to-child transmission of HIV in resource-limited settings: the Elizabeth Glaser Pediatric AIDS Foundation experience. Am. J. Public Health 99:631-637.
84. Stanton, C. K., and S. A. Holtz. 2006. Levels and trends in cesarean birth in the developing world. Stud. Fam. Plann. 37:41-48.
85. Taha, T. E., N. I. Kumwenda, A. Gibbons, R. L. Broadhead, S. Fiscus, V. Lema, G. Liomba, C. Nkhoma, P. G. Miotti, and D. R. Hoover. 2003. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet 362:1171-1177.
86. Taha, T. E., N. I. Kumwenda, D. R. Hoover, S. A. Fiscus, G. Kafulafula, C. Nkhoma, S. Nour, S. Chen, G. Liomba, P. G. Miotti, and R. L. Broadhead. 2004. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. JAMA 292:202-209.
87. Taylor, G. P., and N. Low-Beer. 2001. Antiretroviral therapy in pregnancy: a focus on safety. Drug Saf. 24:683-702.
88. Reference deleted.
89. Thea, D. M., G. Aldrovandi, C. Kankasa, P. Kasonde, W. D. Decker, K. Semrau, M. Sinkala, and L. Kuhn. 2006. Post-weaning breast milk HIV-1 viral load, blood prolactin levels and breast milk volume. AIDS 20:1539-1547.
90. Thior, I., S. Lockman, L. M. Smeaton, R. L. Shapiro, C. Wester, S. J. Heymann, P. B. Gilbert, L. Stevens, T. Peter, S. Kim, E. van Widenfelt, C. Moffat, P. Ndase, P. Arimi, P. Kebaabetswe, P. Mazonde, J. Makhema, K. McIntosh, V. Novitsky, T. H. Lee, R. Marlink, S. Lagakos, and M. Essex. 2006. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-tochild HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 296:794-805.
91. Thomas, P. A., J. Weedon, K. Krasinski, E. Abrams, N. Shaffer, P. Matheson, M. Bamji, A. Kaul, D. Hutson, K. T. Grimm, et al. 1994. Maternal predictors of perinatal human immunodeficiency virus transmission. Pediatr. Infect. Dis. J. 13:489-495.
92. Thorne, C., and M. L. Newell. 2003. Mother-to-child transmission of HIV infection and its prevention. Curr. HIV Res. 1:447-462.
93. Thorne, C., and M. L. Newell. 2007. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern? Drug Saf. 30:203-213.
94. Reference deleted.
95. Vermeer, W., A. E. Bos, J. Mbwambo, S. Kaaya, and H. P. Schaalma. 2009. Social and cognitive variables predicting voluntary HIV counseling and testing among Tanzanian medical students. Patient Educ. Couns. 75:135-140.
96. World Health Organization. 2006, posting date. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants in resource-limited settings: toward universal access. WHO, Geneva, Switzerland. http://www.who.int/hiv/pub/guidelines/pmtct/en/.
97. World Health Organization. 1 November 2007, posting date. Guidance on global scale-up of the prevention of mother-to-child transmission of HIV: towards universal access for women, infants and young children and eliminating HIV and AIDS among children. WHO, Geneva, Switzerland. http://www.who.int/hiv/ pub/guidelines/pmtct-scaleup2007/en/.
98. World Health Organization/Joint United Nations Programme on AIDS. May 2007, posting date. Guidance on provider-initiated HIV testing and counseling in health facilities. WHO, Geneva, Switzerland. http://www.who.int/ hiv/pub/guidelines/pitc2007/en/.